Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net Loss	$ (2,110,209)	$ (1,569,179)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	120,555	50,415
Stock-based compensation	141,686	37,317
Issuance of common stock for consulting services	330,000
Warrants issued in exchange for extension of note payable	21,121
Change in fair value of warrant liability	(68,377)	(171,184)
Change in fair value of derivative liability	(90,155)	(535,535)
Provision for inventory obsolescence	31,752	9,338
Amortization of debt discount and deferred financing costs	601,514	1,250,980
Gain on extinguishment of debt	(2,374)
Changes in operating assets and liabilities:
Accounts receivable	(47)	4,138
Inventory	4,875	4,214
Prepaid expenses and other current assets	25,161	(236,750)
Accounts payable	61,022	(48,807)
Accrued expenses	422,621	184,377
Net cash used in operating activities	(510,855)	(1,020,676)
Cash flows from investing activities:
Purchase of property and equipment		(3,314)
Net cash from CureDM acquisition	3,592
Net cash provided by (used in) investing activities	3,592	(3,314)
Cash flows from financing activities:
Proceeds from issuance of convertible notes payable (net of issuance discounts and fees)		200,000
Repayment of notes payable to related party		(16,288)
Proceeds from issuance of note payable to related parties	405,937
Proceeds from issuance of preferred stock	275,000	450,000
Net cash provided by financing activities	680,937	633,712
Net increase (decrease) in cash and cash equivalents	173,674	(390,278)
Cash and cash equivalents, beginning of year	137,279	687,185
Cash and cash equivalents, end of year	310,953	296,907
Cash paid during the year for:
Interest		7,699
Income taxes
Non-cash financing activities:
Conversion of convertible notes payable and accrued interest into common stock	1,277,066	198,781
Derivative liability associated with convertible note payable	10,617	454,154
Issuance of common stock for the acquisition of CureDM Group Holdings LLC	1,250,000
Contingent share liability and goodwill in acquisition of CureDM Group Holdings LLC	1,137,057
Derivative liability associated with issuance of preferred stock	226,833
Note payable and accrued expenses for prepaid marketing	$ 850,000